Neogen Corporation (NEOG) Financial Statements (2025 and earlier)

Company Profile

Business Address 620 LESHER PLACE
LANSING, MI 48912
State of Incorp. MI
Fiscal Year End May 31
Industry (SIC) 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

11/30/2024
MRQ
5/31/2024
5/31/2023
5/31/2022
5/31/2021
5/31/2020
5/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments170,936245,569381,051381,087343,673267,524
Cash and cash equivalent170,611163,24044,47375,60266,26941,688
Short-term investments 32582,329336,578305,485277,404225,836
Receivables173,005153,25399,67491,82384,68182,582
Inventory, net of allowances, customer advances and progress billings189,267133,812122,313100,70195,05385,992
Inventory189,267133,812122,313100,70195,05385,992
Other undisclosed current assets56,02553,29723,76017,84013,99913,431
Total current assets:589,233585,931626,798591,451537,406449,529
Noncurrent Assets
Operating lease, right-of-use asset14,78511,9333,1842,477 
Property, plant and equipment277,104198,749110,584100,45378,67174,847
Intangible assets, net (including goodwill)3,647,2853,742,599250,207223,792  
Goodwill2,135,6322,137,496142,704131,476  
Intangible assets, net (excluding goodwill)1,511,6531,605,103107,50392,316  
Regulated entity, other noncurrent assets 11,609     
Deferred income tax assets 3,788    
Other noncurrent assets20,42615,2202,1562,019181,105171,364
Other undisclosed noncurrent assets (15,397)     
Total noncurrent assets:3,959,6003,968,501366,131328,741259,776246,211
TOTAL ASSETS:4,548,8334,554,432992,929920,192797,182695,740
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities124,444140,85672,38453,59948,48938,251
Taxes payable2,1261,8481,456601
Employee-related liabilities11,12311,2517,7357,085
Accounts payable83,06176,66934,61423,90025,65019,063
Accrued liabilities41,38364,18724,52116,60013,64811,502
Deferred revenue4,6324,6165,460  
Debt902,447     
Accrued environmental loss contingencies 100     
Other liabilities22,800     
Other undisclosed current liabilities (900,100)     
Total current liabilities:154,323145,47277,84453,59948,48938,251
Noncurrent Liabilities
Long-term debt and lease obligation888,391885,439  913 
Long-term debt, excluding current maturities888,391885,439    
Liabilities, other than long-term debt373,093389,30427,71126,2165,39119,590
Deferred tax liabilities, net15,618
Deferred income tax liabilities326,718353,42717,01121,917 
Accrued environmental loss contingencies 816     
Other liabilities35,25935,87710,7004,2995,3913,972
Operating lease, liability 10,300   913
Other undisclosed noncurrent liabilities (11,116)   17,212 
Total noncurrent liabilities:1,250,3681,274,74327,71126,21623,51619,590
Total liabilities:1,404,6911,420,215105,55579,81572,00557,841
Equity
Equity, attributable to parent3,144,1423,134,217887,374840,377725,177637,899
Common stock34,65834,59917,24817,1958,4718,355
Additional paid in capital2,583,8852,567,828309,984294,953257,693221,937
Accumulated other comprehensive loss(30,021)(33,251)(27,769)(11,375)(19,709)(11,640)
Retained earnings555,620565,041587,911539,604478,722419,247
Total equity:3,144,1423,134,217887,374840,377725,177637,899
TOTAL LIABILITIES AND EQUITY:4,548,8334,554,432992,929920,192797,182695,740

Income Statement (P&L) ($ in thousands)

11/30/2024
TTM
5/31/2024
5/31/2023
5/31/2022
5/31/2021
5/31/2020
5/31/2019
Revenues924,222822,447527,159468,459418,170414,186
Cost of revenue
(Cost of Product and Service Sold)
(460,322)(416,492)(284,146)(253,403)(221,891)(222,266)
Gross profit:463,900405,955243,013215,056196,279191,920
Operating expenses(405,237)(368,440)(184,395)(140,887)(128,756)(123,826)
Operating income (loss):58,66337,51558,61874,16967,52368,094
Nonoperating income (expense)(72,968)(59,557)1,5891,0994,7824,865
Other nonoperating income (expense)(5,936)(6,762)322(515)(1,210)32
Interest and debt expense(42,152)(27,254)    
Income (loss) from continuing operations before equity method investments, income taxes:(56,457)(49,296)60,20775,26872,30572,959
Other undisclosed income from continuing operations before income taxes42,15227,254    
Income (loss) from continuing operations before income taxes:(14,305)(22,042)60,20775,26872,30572,959
Income tax expense (benefit)4,884(828)(11,900)(14,386)(12,830)(12,783)
Income (loss) from continuing operations:(9,421)(22,870)48,30760,88259,47560,176
Income before gain (loss) on sale of properties:48,30760,88259,47560,176
Net income (loss) available to common stockholders, diluted:(9,421)(22,870)48,30760,88259,47560,176

Comprehensive Income ($ in thousands)

11/30/2024
TTM
5/31/2024
5/31/2023
5/31/2022
5/31/2021
5/31/2020
5/31/2019
Net income (loss):(9,421)(22,870)48,30760,88259,47560,176
Other comprehensive income (loss)3,230(5,482)(16,394)8,334(8,069)(1,894)
Comprehensive income (loss), net of tax, attributable to parent:(6,191)(28,352)31,91369,21651,40658,282

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: